GUANGZHOU WISHCARE MEDICAL EQUIPMENT CO., LTD.
HOME-PRODUCT
News Detail

Inventory for the first half of 2021: The golden age of the pharmaceutical industry has passed, and

Issuing time:2017-05-10 00:00

In the past ten years, driven by the government's increased investment in the medical and health industry, China's medical and health market has experienced a stage of rapid development. As the medical reform continues, the pattern of China's medical market will undergo fundamental changes. Zero2IPO Research Center believes that the overall pharmaceutical industry will continue to maintain rapid growth in the future, but the structure will be more optimized. Since the start of the new medical reform, governments at all levels have increased their investment in the construction of medical facilities and equipment renewal. In addition to the steady increase in the number of medical services in China, the Chinese medical device market has ushered in an era of rapid development. Fundamentally solving the problem of using medicines to raise the price of medical services will inevitably be forced to increase the price of medical services. Strong demand and favorable policies will promote the rapid growth of the medical service industry, and mobile medical services will drive the development of medical services and related medical equipment segments.


  The golden age of the pharmaceutical industry has passed, and policy dividends are the key


With the aging population, changes in the disease spectrum, and the continued advancement of medication upgrades, the mid-to-long-term growth trend of the biomedical industry remains unchanged. However, in the short to medium term, medical insurance control fees, bid price cuts, administrative price cuts, and the efficiency of new drug approvals will affect the development of the industry. The impact is more profound; although the state’s regulatory policies on the pharmaceutical industry are complex and changeable, the industry trends behind the policy changes are still relatively clear, such as strengthening the rationality of the use of drugs, encouraging the import substitution of high-generic drugs, and giving priority to the clinical review of urgently needed generic drugs. Comment on optimizing the competitive landscape of the industry, etc.


   Favorable policies & market demand, medical devices enter the fast lane of development


   Since the start of the new medical reform in 2009, governments at all levels have increased investment in the construction of medical facilities and equipment renewal. In addition to the steady increase in the number of medical services in China, the Chinese medical device market has ushered in an era of rapid development. With the improvement of relevant laws and regulations, the policy orientation of the Chinese government in the director of the medical device industry has become clearer, that is, gradually improving regulatory efficiency, encouraging innovation, especially domestic key innovation, and strengthening quality and safety.


  Medical services are the focus of healthcare reform, and mobile healthcare will drive the development of related industries


  The big advantage in the medical reform process is privatization (that is, public hospital reform). Medical services will continue to benefit from the institutional dividends brought about by industry changes in this longer period. At present, medical services currently account for a relatively low proportion of the overall medical and health industry, and there is basically no policy resistance. The policy environment is better than that of the pharmaceutical industry, and the future has huge space. With the rapid growth of the mobile medical market, the evolution from horizontal applications to vertical solutions that open up the mobile medical service value chain will become the industry's development direction.


Share to:
Email:wishcaremedical@foxmail.com
Tel: 008613042033744
Address:Room L1022,No.80,Yong tai Modao South Street,
Yongping Street,Bai yun District,Guangzhou,CHINA